Literature DB >> 24458922

CALR mutations in myeloproliferative neoplasms: hidden behind the reticulum.

Paola Guglielmelli1, Jyoti Nangalia, Anthony R Green, Alessandro M Vannucchi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2014        PMID： 24458922     DOI： 10.1002/ajh.23678

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  12 in total

Review 1.  What Do Molecular Tests Add to Prognostic Stratification in MF: Is It Time to Add These to Our Clinical Practice?

Authors:  Paola Guglielmelli; Giada Rotunno; Annalisa Pacilli; Alessandro Maria Vannucchi
Journal:  Curr Hematol Malig Rep       Date:  2015-12       Impact factor: 3.952

2.  The number of prognostically detrimental mutations and prognosis in primary myelofibrosis: an international study of 797 patients.

Authors:  P Guglielmelli; T L Lasho; G Rotunno; J Score; C Mannarelli; A Pancrazzi; F Biamonte; A Pardanani; K Zoi; A Reiter; A Duncombe; T Fanelli; D Pietra; E Rumi; C Finke; N Gangat; R P Ketterling; R A Knudson; C A Hanson; A Bosi; A Pereira; R Manfredini; F Cervantes; G Barosi; M Cazzola; N C P Cross; A M Vannucchi; A Tefferi
Journal:  Leukemia       Date:  2014-02-19       Impact factor: 11.528

3.  Detection and characterization of homozygosity of mutated CALR by copy neutral loss of heterozygosity in myeloproliferative neoplasms among cases with high CALR mutation loads or with progressive disease.

Authors:  Anna Stengel; Sabine Jeromin; Torsten Haferlach; Manja Meggendorfer; Wolfgang Kern; Claudia Haferlach
Journal:  Haematologica       Date:  2018-11-08       Impact factor: 9.941

4.  Coexisting JAK2V617F and CALR Exon 9 Mutation in Essential Thrombocythemia.

Authors:  Munazza Rashid; Rifat Zubair Ahmed; Shariq Ahmed; Muhammad Nadeem; Nuzhat Ahmed; Tahir Sultan Shamsi
Journal:  Indian J Hematol Blood Transfus       Date:  2016-02-09       Impact factor: 0.900

5.  Analysis of calreticulin mutations in Chinese patients with essential thrombocythemia: clinical implications in diagnosis, prognosis and treatment.

Authors:  R Fu; M Xuan; Y Zhou; T Sun; J Bai; Z Cao; L Zhang; H Li; D Zhang; X Zhang; C Lv; F Xue; X Liu; R Yang; L Zhang
Journal:  Leukemia       Date:  2014-04-15       Impact factor: 11.528

6.  Targeted deep sequencing in primary myelofibrosis.

Authors:  Ayalew Tefferi; Terra L Lasho; Christy M Finke; Yoseph Elala; Curtis A Hanson; Rhett P Ketterling; Naseema Gangat; Animesh Pardanani
Journal:  Blood Adv       Date:  2016-11-30

7.  Distinct clinical characteristics of myeloproliferative neoplasms with calreticulin mutations.

Authors:  Hajnalka Andrikovics; Tunde Krahling; Katalin Balassa; Gabriella Halm; Andras Bors; Magdalena Koszarska; Arpad Batai; Janos Dolgos; Judit Csomor; Miklos Egyed; Andrea Sipos; Peter Remenyi; Attila Tordai; Tamas Masszi
Journal:  Haematologica       Date:  2014-06-03       Impact factor: 9.941

8.  JAK2 V617F, MPL, and CALR Mutations in Korean Patients with Essential Thrombocythemia and Primary Myelofibrosis.

Authors:  Bo Hyun Kim; Young-Uk Cho; Mi-Hyun Bae; Seongsoo Jang; Eul-Ju Seo; Hyun-Sook Chi; Yunsuk Choi; Dae-Young Kim; Jung-Hee Lee; Je-Hwan Lee; Kyoo-Hyung Lee; Young-Mi Park; Jong-Keuk Lee; Chan-Jeoung Park
Journal:  J Korean Med Sci       Date:  2015-06-10       Impact factor: 2.153

9.  Detection of MPLW515L/K mutations and determination of allele frequencies with a single-tube PCR assay.

Authors:  Hiraku Takei; Soji Morishita; Marito Araki; Yoko Edahiro; Yoshitaka Sunami; Yumi Hironaka; Naohiro Noda; Yuji Sekiguchi; Satoshi Tsuneda; Akimichi Ohsaka; Norio Komatsu
Journal:  PLoS One       Date:  2014-08-21       Impact factor: 3.240

10.  MARIMO cells harbor a CALR mutation but are not dependent on JAK2/STAT5 signaling.

Authors:  K Kollmann; J Nangalia; W Warsch; H Quentmeier; A Bench; E Boyd; M Scott; H G Drexler; A R Green
Journal:  Leukemia       Date:  2014-09-24       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.